MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Zoiray Technologies Inc., Boston
Zoiray makes a simple-to-use tabletop units that scan binding interactions in real time, label-free.
David Bergstein, President & CEO
Linda Smith, VP of Marketing
David Bergstein, M. Selim Unlu, Charles DeLisi
Zoíray has sold three prototype instruments in the life science research market. The instruments are simple-to-use tabletop units that scan binding interactions in real time, label-free.
A simpler, next-generation instrument is in development and will be supplied with slides featuring Zoiray’s proprietary high-performance surface chemistry. The non-conforming 3D surface optimizes probe activity and resists non-specific binding for clean repeatable results. Ultimately, Zoiray will sell diagnostic chips for clinical in vitro monitoring of disease.